FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

9 results

fenofibrate
(fenofibrate)
Mylan Pharmaceuticals Inc.
Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for adults with primary hypercholesterolemia or mixed dyslipidemia, aiming to improve cholesterol levels. They are also used for treating severe hypertriglyceridemia, although their effect on reducing coronary heart disease risks in type 2 diabetes patients remains unproven.
fenofibrate
(fenofibrate)
Solco Healthcare US, LLC
Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for adults with primary hypercholesterolemia, mixed dyslipidemia, or severe hypertriglyceridemia. They help reduce LDL-C, total cholesterol, triglycerides, and Apo B, while increasing HDL-C. They do not reduce coronary heart disease morbidity or mortality in diabetes patients.
fenofibrate
(Fenofibrate)
Macleods Pharmaceuticals Limited
Usage: Fenofibrate is indicated as adjunctive therapy to diet for reducing low-density lipoprotein cholesterol, triglycerides, and apolipoprotein B while increasing high-density lipoprotein cholesterol in adults with primary hypercholesterolemia or mixed dyslipidemia and for treating severe hypertriglyceridemia.
fenofibrate
(Fenofibrate)
Alembic Pharmaceuticals Inc.
Usage: Fenofibrate is indicated as adjunctive therapy to diet for reducing LDL cholesterol, total cholesterol, triglycerides, and Apo B in adults with primary hypercholesterolemia and mixed dyslipidemia, as well as for managing hypertriglyceridemia in specific Fredrickson types. It is not suitable for type I hyperlipoproteinemia.
fenofibrate
(Fenofibrate)
Alembic Pharmaceuticals Inc.
Usage: Fenofibrate tablets are indicated as adjunctive therapy to diet for reducing LDL-C, total cholesterol, triglycerides, and apolipoprotein B, while increasing HDL-C in adults with primary hypercholesterolemia or mixed dyslipidemia, and for treating severe hypertriglyceridemia. Limitations include lack of efficacy in reducing coronary heart disease risks in diabetic patients.
fenofibric acid
(Fenofibric acid)
Micro Labs Limited
Usage: Fenofibric acid delayed-release capsules are indicated as adjunctive therapy to diet for reducing triglycerides in severe hypertriglyceridemia and for lowering LDL cholesterol, total cholesterol, triglycerides, and apolipoprotein B, while increasing HDL cholesterol in patients with primary hypercholesterolemia or mixed dyslipidemia.
lovastatin
(lovastatin)
Lupin Pharmaceuticals, Inc.
Usage: Lovastatin is indicated for lowering total and LDL cholesterol levels as part of a treatment strategy in individuals with dyslipidemia at risk for atherosclerotic vascular disease, including those with coronary heart disease and hypercholesterolemia. It is also used for primary prevention of coronary heart disease in certain populations.
niacin
(Niacin)
Chartwell RX, LLC
Usage: Niacin extended-release tablets are indicated as an adjunct to diet for reducing elevated cholesterol and triglycerides, increasing HDL, and decreasing the risk of recurrent myocardial infarction in hyperlipidemic patients. It also helps slow atherosclerotic disease progression in those with a history of coronary artery disease.
rosuvastatin calcium
(ROSUVASTATIN CALCIUM)
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Usage: Rosuvastatin is indicated to treat hyperlipidemia, mixed dyslipidemia, hypertriglyceridemia, primary dysbetalipoproteinemia, and homozygous familial hypercholesterolemia. It aids in slowing atherosclerosis progression and primary prevention of cardiovascular disease in at-risk adults. It should be used alongside dietary management.

Medications for Dyslipidemias

fenofibrate

fenofibrate

fenofibrate

fenofibrate

fenofibrate

fenofibric acid

lovastatin

niacin

rosuvastatin calcium